top of page

Solving the Study Design Dilemma

DOWNLOAD OUR ROUNDTABLE INSIGHTS SUMMARY

Navigating compressed project timelines, hard-to-reach user populations, and evolving regulatory expectations remains a persistent industry challenge.

​

Following our recent peer-to-peer roundtable at the 2026 TT LifeSciences HF/UE Conference in Amsterdam, we have consolidated the core recommendations, shared solutions, and insights into a concise summary.

What is Inside:
 

  • Process Reliability & Redundancy: Moving to a supply-chain mindset to mitigate late-stage participant no-shows.

  • Preventing Sample Size Escalation: Aligning cohort quotas strictly with critical tasks to manage regulatory defense efficiently.

  • Complex Session Design: Formulating defensible evaluation protocols that capture real-world clinical team dynamics.

  • Post-Validation Modifications: Evaluating late-stage design modifications using targeted simulated-use protocols and cascade assessments.

bottom of page